Data of the MetS and control groups
Variables | Diabetics with MetS | Diabetics without MetS | p | |
---|---|---|---|---|
Mean ± SD or Median (min.–max.) | Mean ± SD or Median (min.–max.) | |||
Sex | Men (n,%) | 67 (37%) | 21 (36%) | 0.84 |
Women (n,%) | 113 (63%) | 38 (64%) | ||
UCR | 6.3 ± 2.1 | 5.8 ± 1.6 | 0.04 | |
Hb (g/dL) | 13 ± 1.8 | 13 ± 1.8 | 0.58 | |
PLT (k/mm3) | 278 ± 78 | 257 ± 70 | 0.26 | |
Age (years) | 59 (24–85) | 57 (34–82) | 0.31 | |
SBP (mmHg) | 130 (90–180) | 129 (100–130) | 0.009 | |
DBP (mmHg) | 80 (60–120) | 79 (60–95) | 0.51 | |
Weight (kg) | 81(50–150) | 78 (38–131) | 0.002 | |
Height (cm) | 162 (140–184) | 162 (135–185) | 0.12 | |
Waist circumference (cm) | 108 (70–144) | 99 (54–134) | < 0.001 | |
Hip circumference (cm) | 112 (91–155) | 112(53–133) | 0.001 | |
WHiR | 0.94 (0.6–1.2) | 0.94 (0.52–1.77) | 0.22 | |
BMI (kg/m2) | 30 (21–51) | 28 (21–51) | < 0.001 | |
WHR | 0.65 (0.47–0.87) | 0.62 (0.35–0.84) | < 0.001 | |
Leukocyte count (k/mm3) | 7.7 (3.3–16.5) | 6.8 (3.9–12.4) | 0.008 | |
Htc (%) | 39 (30–50) | 39 (30–52) | 0.66 | |
Creatinine (mg/dL) | 1 (0.5–6) | 0.9 (0.6–2) | 0.09 | |
eGFR (%) | 79 (7–124) | 90 (33–118) | 0.005 | |
Total cholesterol (mg/dL) | 191 (81–373) | 191 (107–286) | 0.57 | |
LDL-cholesterol (mg/dL) | 109 (31–345) | 109 (44–182) | 0.08 | |
HDL-cholesterol (mg/dL) | 46 (21–100) | 53 (34–99) | < 0.001 | |
Triglyceride (mg/dL) | 167 (46–484) | 102 (49–310) | < 0.001 | |
Albumin (g/dL) | 45 (32–58) | 46 (38–52) | 0.34 | |
Uric acid (mg/dL) | 5.6 (2.4–13.5) | 5 (2.6–12) | < 0.001 | |
Fasting blood glucose (mg/dL) | 160 (70–573) | 151 (64–418) | 0.005 | |
HbA1c (%) | 8.1 (4.7–18) | 7.3 (5–15) | 0.79 |
UCR: uric acid-to-creatinine ratio; Hb: hemoglobin; PLT: platelet count; SBP: systolic blood pressure; DBP: diastolic blood pressure; WHiR: waist to hip ratio; BMI: body mass index; WHR: waist-to-height ratio; Htc: hematocrit; eGFR: estimated glomerular filtration rate; HbA1c: glycated hemoglobin; MetS: metabolic syndrome